Clinical Trial Materials (CTM) Tool & User Guide

The CTM Data Tool is a database that consolidates information on organizations with production facilities capable of producing clinical trial materials (CTM) for vaccine development. It includes details on each organization’s capabilities, manufacturing technologies, analytical services, regulatory status, and business characteristics.

The tool is designed for vaccine developers, global health organizations, and decision-makers seeking to identify potential CTM suppliers aligned with specific technical, regulatory, and logistical requirements.

To facilitate more efficient supplier identification and due diligence, helping developers select CTM facilities that can meet their product development and clinical trial needs.

The tool is provided as a structured spreadsheet, with multiple tabs containing organizational profiles and reference data. Users can filter or sort by organization location, manufacturing platform, or other variables to narrow their search in the Table of Contents tab.

To request updates to the master dataset, please fill out the form on our contact page.

Each record typically includes: headquarters and facility locations, manufacturing platforms and production capacity, raw materials sourcing and suppliers, filling and packaging capabilities, analytical testing services, quality assurance and regulatory credentials, and business considerations.

The information available for each organization is dependent on the completeness of their survey response and/or information available in the public domain.

The data were collected through structured surveys completed by organizations identified with CTM production capabilities, and was complemented by secondary research and validation of public information. Each data point aligns with a corresponding section in the CTM Facility User Guide.

The user guide provides interpretive context for each data field — explaining the relevance of the information for developer decisions regarding potential partners/suppliers for CTM production.

The user guide provides interpretive context for each data field — explaining the relevance of the information for developer decisions regarding potential partners/suppliers for CTM production.

Organizations report experience across various vaccine manufacturing platforms, such as cell-based or egg-based production systems, recombinant protein expression platforms, and viral vector or nucleic acid technologies.

Each organization lists the number of production suites and batch scale (liters per batch) per platform, allowing developers to assess whether capacity aligns with anticipated clinical trial requirements.

Note: this information is limited to the organization which responded to the survey and elected to provide the above information.

Yes. The tool captures vial sizes, fill rates, and non-vial delivery options (e.g., prefilled syringes or intranasal devices) — critical for assessing end-to-end manufacturing readiness.

Organizations report on their Standard Operating Procedures (SOPs), cGMP certification status, inspection history, and Qualified Person (QP) release capabilities.

Yes. The tool includes details on physicochemical, biological, stability, and immunogenicity testing capabilities, and whether these services are performed in-house or outsourced.

Organizations indicate whether they have supported IND or equivalent submissions, which helps gauge their familiarity with regulatory documentation and filing processes.

The tool captures operational insights such as backlog and wait times, use of proprietary platforms, and licensing terms for proprietary technology.

For questions, data corrections, or update requests, please fill out the form on our contact page.

Yes, the data is structured to allow integration with broader pipeline tracking or partner databases through standard formats like CSV or XLSX.

Users can share comments and improvement suggestions by filling out the form on our contact page. Feedback helps prioritize new features and improve clarity.